[Clinical pharmacology and adverse effects of various anti-arrhythmic drugs].
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects* / Q000494:pharmacology; D001855:Bone Marrow Diseases / Q000139:chemically induced; D002493:Central Nervous System Diseases / Q000139:chemically induced; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006331:Heart Diseases / Q000139:chemically induced; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects; D007545:Isoproterenol / Q000009:adverse effects; D008012:Lidocaine / Q000009:adverse effects; D008564:Membrane Potentials / Q000187:drug effects; D010672:Phenytoin / Q000009:adverse effects; D010946:Plants, Medicinal; D011342:Procainamide / Q000009:adverse effects; D011802:Quinidine / Q000009:adverse effects; D011926:Rauwolfia / Q000009:adverse effects; D014700:Verapamil / Q000009:adverse effects
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D007093:Imidazoles; D010672:Phenytoin; D008012:Lidocaine; D014700:Verapamil; D011802:Quinidine; D011342:Procainamide; D007545:Isoproterenol
Klinische Pharmakologie und Nebenwirkungen einiger Antiarrhythmika.